Focal cerebral ischemia in the mouse: Hypothermia and rapid screening of drugs

General Pharmacology

Volumn 30, Issue 2, 1998, Pages 195-200

  Cramer, Willy C M ^a   Toorop, G Paul ^a  

^a Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Ca++ antagonists; Excitatory amino acids; Focal cerebral ischemia drug effects; Hypothermia; Mice

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; CALCIUM ANTAGONIST; DILTIAZEM; EMOPAMIL; EXCITATORY AMINO ACID; IFENPRODIL; IPSAPIRONE; LIFARIZINE; N [1 [4 (4 FLUOROPHENOXY)BUTYL] 4 PIPERIDINYL] N METHYL 2 BENZOTHIAZOLAMINE; NIMODIPINE; SABELUZOLE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; HEART INFARCTION SIZE; HYPOTHERMIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE;

ANIMALS; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; HYPOTHERMIA; IMIDAZOLES; MALE; MICE; NEUROPROTECTIVE AGENTS; PHENYL ETHERS; PIPERAZINES; PYRIMIDINES;

EID: 0032007874     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00109-2     Document Type: Article

References (33)

1. Alps B. J. (1992) Drugs acting on calcium channels: potential treatment for ischaemic stroke. Br. J. Clin. Pharmac. 34, 199-206.
2. Backhauss C., Karkoutly C., Welsch M. and Krieglstein J. (1992) A mouse model of focal cerebral ischemia for screening neuroprotective drug effects. J. Pharmac. Meth. 27, 27-32.
3. Barone F. C., Knudsen D. J., Nelson A. H., Feuerstein G. Z. and Willette R. N. (1993) Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy. J. Cereb. Blood Flow Metab. 13, 683-692.
4. 1A agonists: a new therapeutic principle tor stroke treatment. Stroke 21(suppl. IV), IV161-IV163.
5. Boddeke E., Hugtenburg J., Jap W., Heynis J. and Van Zwieten P. A. (1989) New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects. Trends Pharmac. Sci. 10, 397-400.
6. 1C) in microsomal and nuclear fractions of rat liver. Agents Actions(supp. 33), 325-342.
7. Brown C. M., Calder C., Alps B. J. and Spedding M. (1993) The effect of lifarizine (RS-87476), a novel sodium and calcium channel modulator, on ischaemic dopamine depletion in the corpus striatum of the gerbil. Br. J. Pharmac. 109, 175-177.
8. Brown C. M., Calder C., Linton C., Small C., Kenny B. A., Spedding M. and Patmore L. (1995) Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischemia. Br. J. Pharmac. 115, 1425-1432.
9. Chen H., Chopp M., Zhang Z. G. and Garcia J. H. (1992) The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 12, 621-628.
10. Chopp M., Chen H., Dereski M. O. and Garcia J. H. (1991) Mild hypothermic intervention after graded ischemic stress in rats. Stroke 22, 37-43.
11. Contreras P. C., Gray N. M., Ragan D. M. and Lanthorn T. H. (1992) BMY-14802 protects against ischemia-induced neuronal damage in the gerbil. Life Sci. 51, 1145-1149.
12. Earley B., Canney M., Clune B., Caldwell M., Leonard B. E. and Junien J.-L. (1996) The effects of MK-801, Ifenprodil, JO 1784, JO 1994 and JO 1997 on PK 11195 receptor binding, nitric oxide synthase (NO synthase) activity and infarct volume in a mouse model of focal cerebral ischemia. Neurochem. Int. 28, 509-521.
13. Gill R., Nordholm L. and Lodge D. (1992) The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res. 580, 35-43.
14. Gotti B., Duverger D., Bertin J., Carter C., Dupont R., Frost J., Gaudilliere B., MacKenzie E. T., Rousseau J., Scatton B. and Wick A. (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J. Pharmac. Exp. Ther. 247, 1211-1221.
15. Gotti B., Benavides J., MacKenzie E. T. and Scatton B. (1990) The pharmacotherapy of focal cortical ischemia in the mouse. Brain Res. 522, 290-307.
16. Isayama K., Pitts L. H. and Nishimura M. C. (1991) Evaluation of 2,3,5-Triphenyltetrazolium chloride staining to delineate rat brain infarcts. Stroke 22, 1394-1398.
17. Izumi Y., Roussel S., Pinard E. and Seylaz J. (1991) Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 11, 1025-1030.
18. Karkoutly C., Backhauss C., Nuglisch J. and Krieglstein J. (1990) The measurement of the infarcted area after middle cerebral artery occlusion in the mouse: a screening model. In Pharmacology of Cerebral Ischemia (Edited by Krieglstein J. and Oberpichter H.), pp. 63-69. Wissenschaftliche Verlagsgesellschaft, Stuttgart.
19. Kucharczyk J., Mintorovitch J., Moseley M. E., Asgari H. S., Sevick R. J., Derugin N. and Norman D. (1991) Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476. Radiology 179, 221-227.
20. Lippert K., Welsch M. and Krieglstein J. (1994) Over-additive protective effect of dizocilpine and NBQX against neuronal damage. Eur. J. Pharmac. 253, 207-213.
21. Lipton S. A. (1993) Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16, 527-532.
22. Lundy E. F., Solik B. S., Frank R. S., Lacy P. S., Combs D. J., Zelenock G. B. and D'Alecy L. G. (1986) Morphometric evaluation of brain infarcts in rats and gerbils. J. Pharmac. Meth. 16, 201-214.
23. Macrae I. M. (1992) New models of focal cerebral ischemia. Br. J. Clin. Pharmac. 34, 302-308.
24. Morikawa E., Ginsberg M. D., Dietrich W. D., Duncan R. C., Kraydieh S., Globus M. Y.-T, and Busto R. (1992) The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 12, 380-389.
25. 1A-agonist CM57493 on infarct area, infarct volume and hippocampal neuronal damage after focal and global ischemia in mice and in rats. In Pharmacology of Cerebral Ischemia (Edited by Krieglstein Y. and Oberpichler H.), pp. 493-497. Wissenschaftliche Verlagsgesellschaft, Stuttgart.
26. Pauwels P. J., Van Assouw H. P., Peeters L., Moeremans M. and Leysen J. E. (1992) Chronic treatment with sabeluzole protects cultured rat brain neurons from the neurotoxic effects of excitatary amino acids. Synapse 12, 271-280.
27. 1A receptor agonists in rodent models of focal and global cerebral ischemia. Eur. J. Pharmac. 203, 213-222.
28. Ridenour T. R., Warner D. S., Todd M. M. and McAllister A. C. (1992) Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischemia in rats. Stroke 23, 733-738.
29. Scatton B., Carter C., Benavides J. and Giroux C. (1991) N-methyl-D-aspartate receptor antagonists: a novel therapeutic perspective for the treatment of ischemic brain injury. Cerebrovasc. Dis. 1, 121-135.
30. Tamura A., Graham D. I., McCulloch J. and Teasdale G. M. (1981) Focal cerebral ischemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1, 53-60.
31. Verdonck L. and Borgers M. (1991) Myocardial protection by R56865: a new principle based on prevention of ion channel pathology. Am. J. Physiol. 261 (Heart Circ. Physiol. 30), H1828-H1835.
32. Wauquier A., Clincke G., Ashton D., De Ryck M., Fransen J. and Van Clemen G. (1986) R58735: a new antihypoxic drug with anticonvulsant properties and possible effects on cognitive functions. Drug Dev. Res. 8, 373-380.
33. Welsh F. A., Sakamoto T., McKee A. E. and Sims R. E. (1987) Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain. J. Neurochem. 49, 846-851.